Z-2322-2025 Class II Ongoing
FDA device recall Z-2322-2025 was initiated by Beckman Coulter, Inc. on Jul 10, 2025 and is designated Class II. Reason for recall: Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging… The recall status is ongoing. Affected quantity: 453 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 20, 2025
- Initiation Date
- Jul 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 453 units
Product description
Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860
Reason for recall
Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging studies and/or inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.
Distribution pattern
Worldwide - US Nationwide and the countries of Brazil, Canada, Georgia, Italy, Malaysia, Mexico, Philippines, Spain.
Code information
UDI-DI: 15099590227173; Lot Number: 439163
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2322-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026